Atlas Trials

Phase II Study of NGC-Triple Regimen in Potentially Resectable Pancreatic Cancer Patients

Clinical trial NCT03392571 · WITHDRAWN

Trial details

NCT number
NCT03392571
Sponsor
Pancreatic Cancer Research Team
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Resectable Pancreatic Cancer
Start date
2018-08-15
Primary completion
2020-12-30
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.